Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological invasions alter environmental microbiomes: A meta-analysis.
Malacrinò A, Sadowski VA, Martin TK, Cavichiolli de Oliveira N, Brackett IJ, Feller JD, Harris KJ, Combita Heredia O, Vescio R, Bennett AE. Malacrinò A, et al. Among authors: vescio r. PLoS One. 2020 Oct 22;15(10):e0240996. doi: 10.1371/journal.pone.0240996. eCollection 2020. PLoS One. 2020. PMID: 33091062 Free PMC article.
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.
Berenson JR, Limon A, Rice S, Safaie T, Boccia R, Yang H, Moezi M, Lim S, Schwartz G, Eshaghian S, Brobeck M, Swift R, Eades BM, Bujarski S, Sebhat Y, Ray R, Kim S, Del Dosso A, Vescio R. Berenson JR, et al. Among authors: vescio r. Target Oncol. 2024 Apr 20. doi: 10.1007/s11523-024-01049-w. Online ahead of print. Target Oncol. 2024. PMID: 38643346
Low booster uptake in cancer patients despite health benefits.
Figueiredo JC, Levy J, Choi SY, Xu AM, Merin NM, Hamid O, Lemos T, Nguyen N, Nadri M, Gonzalez A, Mahov S, Darrah JM, Gong J, Paquette RL, Mita AC, Vescio RA, Salvy SJ, Mehmi I, Hendifar AE, Natale R, Tourtellotte WG, Krishnan Ramanujan V, Huynh CA, Sobhani K, Reckamp KL, Merchant AA. Figueiredo JC, et al. Among authors: vescio ra. medRxiv [Preprint]. 2023 Oct 26:2023.10.25.23297483. doi: 10.1101/2023.10.25.23297483. medRxiv. 2023. PMID: 37961284 Free PMC article. Preprint.
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Free PMC article. Clinical Trial.
Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study.
Gordan LN, Tan CR, Vescio R, Ye JC, Schinke C, Medhekar R, Fu AZ, Lafeuille MH, Thompson-Leduc P, Khare V, Reitan J, Milkovich G, Kaila S, Davies F, Usmani SZ. Gordan LN, et al. Among authors: vescio r. Clin Lymphoma Myeloma Leuk. 2024 Jan;24(1):55-63. doi: 10.1016/j.clml.2023.09.003. Epub 2023 Sep 14. Clin Lymphoma Myeloma Leuk. 2024. PMID: 37838502 Free article.
Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
Dhillon M, Kobashigawa JA, Kittleson M, Jain R, Patel N, Singer-Englar T, Zhang X, Hakimi M, Aintablian T, Vescio R, Dilibero D, Kransdorf E, Czer L, Nikolova AP, Patel JK. Dhillon M, et al. Among authors: vescio r. Clin Transplant. 2024 Jan;38(1):e15165. doi: 10.1111/ctr.15165. Epub 2023 Oct 14. Clin Transplant. 2024. PMID: 37837612 Review.
119 results